Fact or Fiction: Bladder Cancer
Medscape,
Recent advances in immunotherapy, genomic profiling, and bladder-sparing techniques have begun to reshape diagnostic algorithms…
CG0070 Plus Nivolumab Under Investigation in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
OncLive,
In Partnership With: The safety and efficacy of the combination of the oncolytic immunotherapy CG0070 and nivolumab is under…
Metastatic Urothelial Carcinoma: A Model Malignancy for Immune Checkpoint Blockade
The ASCO Post,
Advertisement “After several decades without advances, nivolumab is now the second drug to receive regulatory approval for the…
Better understanding of bladder cancer subtypes might lead to improved treatments
MedicalXpress,
An international multidisciplinary team of researchers from a number of institutions, including, Brigham and Women's Hospital…